Financials

  • Market Capitalization 296.45 M
  • Employee 92
  • Founded 2019
  • CEO N/A
  • Website www.neumoratx.com
  • Headquarter Delaware, United States
  • FIGI BBG012W9C4X1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.23
Price to sales ratio
-592.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3354
ELDN
Eledon Pharmaceuticals, Inc. - Common Stock
3.86 USD+0.26%-3.26%+6.93%-5.16%297.94 M USD
3355
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.63 USD0.00%-1.13%-27.35%+38.42%297.83 M USD
3386
MGNX
MacroGenics, Inc. - Common Stock
4.50 USD+3.93%-2.17%+13.64%+186.62%286.03 M USD
3390
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.73 USD-2.36%-4.60%+8.43%+54.13%285.21 M USD

Frequently asked questions about Neumora Therapeutics, Inc. - Common Stock

What is the Neumora Therapeutics, Inc. - Common Stock stock price today?

The current price of Neumora Therapeutics, Inc. - Common Stock (NMRA) is 1.6. Over the past 24 hours, the stock has changed by -4.76%. Follow the NMRA chart for real-time price dynamics.

What is the stock ticker of Neumora Therapeutics, Inc. - Common Stock?

Neumora Therapeutics, Inc. - Common Stock trades under the ticker NMRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Neumora Therapeutics, Inc. - Common Stock stock going up?

NMRA has changed by -4.19% over the last week, +72.04% over the last month, and +24.03% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Neumora Therapeutics, Inc. - Common Stock net income for the last quarter?

Neumora Therapeutics, Inc. - Common Stock reported net income of -53.46 M for the last quarter. The previous quarter showed -59.45 M, which means net income changed by +10.08%.

How many employees does Neumora Therapeutics, Inc. - Common Stock have?

As of the latest available data, Neumora Therapeutics, Inc. - Common Stock has 92 employees. Workforce size can provide additional context about the company's scale and operations.

What is Neumora Therapeutics, Inc. - Common Stock EBITDA?

Neumora Therapeutics, Inc. - Common Stock EBITDA is -52.78 M, and its EBITDA margin is -74.35 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Neumora Therapeutics, Inc. - Common Stock stock?

You can buy Neumora Therapeutics, Inc. - Common Stock (NMRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Neumora Therapeutics, Inc. - Common Stock stock?

Investing in Neumora Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NMRA chart and related analysis on metatrader.com as part of your research.

News